Skip to main content
Menu

Posts tagged with "Press Coverage"

  • Cancer

    For Immediate Rewording. Uh, Release.

    Here’s a nice look at why you should always think about the source of the financial and business information you read. It details the response to a recent Pfizer press release about palbociclib, a CDK inhibitor that’s in late clinical trials. Someone at The Wall Street Journal wrote that it had “the potential. . .to… Read More
  • Chemical News

    The West Virginia Formaldehyde Claim Is Nonsense

    This morning I heard reports of formaldehyde being found in Charleston, West Virginia water samples as a result of the recent chemical spill there. My first thought, as a chemist, was “You know, that doesn’t make any sense”. A closer look confirmed that view, and led me to even more dubious things about this news… Read More
  • Chemical News

    A Long Fight Over Allegations of Fraud

    Here’s a long article from the Raleigh News and Observer (part one and part two) on the Eaton/Feldheim/Franzen dispute in nanoparticles, which some readers may already be familiar with (I haven’t covered it on the blog myself). The articles are clearly driven by Franzen’s continued belief that research fraud has been committed, an… Read More
  • Press Coverage

    More Worthless Press Releases

    To go along with those nominations for worst press releases of the year, here’s a roundup of stinkers in the biomedical field. And they do reek. I got some of these in my in-box as well, and I probably got even more of them than I remember. Sad to say, PR material (or at least… Read More
  • Press Coverage

    Worst Scientific Press Releases of 2013?

    In the same spirit as Adam Feuerstein’s “Worst Biotech CEO” nominations from the other day, here’s Michael Eisen asking what the worst scientific press releases of the year were. Most Overhyped and Most Egregious Failure to Cite Earlier Work are two especially hard categories to win. If you have some examples that particular… Read More
  • Press Coverage

    An Alzheimer’s Cure? Not So Fast.

    The British press (and to a lesser extent, the US one) was full of reports the other day about some startling breakthrough in Alzheimer’s research. We could certainly use one, but is this it? What would an Alzheimer’s breakthrough look like, anyway? Given the complexity of the disease, and the difficulty of extrapolating from its… Read More
  • Cancer

    Overselling p53 Drugs

    You may have seen some “wonder drug” news stories over the holiday break about compounds targeting p53 – many outlets picked up this New York Times story. The first paragraph probably got them: For the first time ever, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of… Read More
  • Chemical Biology

    More on the Parabon NSF Press Release

    Well, I’ve been away from the computer a good part of the day, but I return to find that the author of the NSF press release that I spoke unkindly of has shown up in the comments to that post. I’m going to bring those up here to make sure that his objections get a… Read More
  • Chemical Biology

    Parabon’s DNA Structures: What The Hey?

    I’m having a real problem understanding this press release from the NSF. I’ve been looking at it for a few days now (it’s been sent to me a couple of times in e-mail), and I still can’t get a handle on it. And I’m not the only one. I see just this morning that Chemobber… Read More
  • Press Coverage

    Pfizer’s Gold Dust Makes it to the WSJ

    I wanted to congratulate the commenters around here – your knowledge (and your low-pH wit) have propelled the Pfizer gold dust speculation here to Peter Loftus’ Corporate Intelligence blog at the Wall Street Journal. Don’t expect any response from Pfizer, though. . . Read More
...345...